$1.79
-0.035-1.92%
Last update: Nov 10, 7:23 PM
Voyager Therapeutics Inc
VYGRNASDAQ
Voyager Therapeutics fell 57.2% from $4.26 to $1.83, behind the S&P 500's +9.8%. Its worst day was May 15 (−11.2%), and its low came Oct 30 at $1.72.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.46 beat the $-0.52 estimate on $15.3M revenue (est. $10.2M).
+21.7%, the year's best day, on 5M shares, the year's heaviest volume · S&P 500 −0.2%
Story events cover the past 12 months · Times ET
EPS of $-0.47 beat the $-0.54 estimate on $2.6M revenue (est. $9.0M).
+2.3% · S&P 500 +0.8%
EPS of $-0.40 beat the $-0.52 estimate on $3.2M revenue (est. $4.3M).
+4.5% · S&P 500 +0.6%
EPS of $-0.40 beat the $-0.42 estimate on $4.0M revenue (est. $6.0M).
+8.4% · S&P 500 +0.3%
Where it ended: a close of $1.82 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 8, 2027 (EPS est. $-0.38, revenue est. $7.9M).
Nothing in the past 12 months.
All VYGR dividend historyReplay the year: the line draws itself and stops at each of the 4 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VYGR and SPY from Benzinga historical bars. Not investment advice.
